Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CARDIZEM CD

02 1CARDIZEM LA

03 1CONZIP

04 1DILTIAZEM HYDROCHLORIDE

05 1DILTZAC

06 1DIVALPROEX SODIUM

07 1MORPHABOND ER

08 1NAPROXEN SODIUM

09 1ROXYBOND

10 1SOLOSEC

11 1TAMSULOSIN HYDROCHLORIDE

12 1TAZTIA XT

13 1TIAZAC

14 1VENLAFAXINE HYDROCHLORIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow

02

2024 ACI Convention
Not Confirmed
arrow

03

2024 ACI Convention
Not Confirmed
arrow

04

2024 ACI Convention
Not Confirmed
arrow

05

2024 ACI Convention
Not Confirmed
arrow

06

2024 ACI Convention
Not Confirmed
arrow

07

2024 ACI Convention
Not Confirmed
arrow

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DIVALPROEX SODIUM

Drug : DIVALPROEX SODIUM

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 209286

Country : US

Patented : No

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

VENLAFAXINE HYDROCHLORIDE

Drug : VENLAFAXINE HYDROCHLORIDE

Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

Application Number : 90174

Country : US

Patented : No

blank

10

OHEMO LIFE

Morphine Sulfate

2024 ACI Convention
Not Confirmed
arrow
OHEMO LIFE
arrow
2024 ACI Convention
Not Confirmed

MORPHINE SULFATE

Drug : MORPHABOND ER

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 206544

Country : US

Patented : Yes

blank